Pilot Study: Assessing the Expression of Serum Lactate Dehydrogenase and Peripheral Leukocyte Ratios in Canine Oral Malignant Melanoma
Measurement of blood biomarkers such as lactate dehydrogenase (LDH) and peripheral leukocyte ratios have been shown to be of prognostic value in human melanoma patients. Previous veterinary studies have demonstrated that changes in these values are detectable in multiple canine cancer patients. Howe...
Main Authors: | Ben Murray, Kelly L. Bowlt Blacklock |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/9/8/421 |
Similar Items
-
Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
by: Karen Koo, et al.
Published: (2023-03-01) -
The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer
by: Qin Chen, et al.
Published: (2023-06-01) -
COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour
by: Tatiany L. Silveira, et al.
Published: (2021-08-01) -
Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma
by: Saeed Daneshmandi, et al.
Published: (2019-03-01) -
A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma
by: Ramón M. Almela, et al.
Published: (2019-02-01)